Partial Restoration of Left Ventricular Systolic Function by asPLB Gene Transfer Using Ultrasound-Mediated Microbubble Destruction

Ultrasound in Medicine and Biology

Volumn 35, Issue 10, 2009, Pages 1638-1646

  Mou, Yun ^a   Ye, Yang ^a   Zhao, Xiao Yan ^a   Yao, Lei ^a   Yan, Li Ping ^b   Sun, Jian ^a   Zhu, Zhao Hui ^a   Hu, Shen Jiang ^a,c  

^a ZHEJIANG UNIVERSITY   (China)

^b First Affiliated Hospital   (China)

^c Immunology Division   (China)

Author keywords

Antisense phospholamban; Cardiac sarcoplasmic reticulum Ca2+ ATPase; Left ventricular function; Myocardial infarction; Ultrasound mediated microbubble destruction

Indexed keywords

ANTISENSE PHOSPHOLAMBAN; CARDIAC SARCOPLASMIC RETICULUM CA2+ ATPASE; LEFT VENTRICULAR FUNCTION; MYOCARDIAL INFARCTION; ULTRASOUND MEDIATED MICROBUBBLE DESTRUCTION;

CALCIUM; GENE TRANSFER; NUCLEIC ACIDS; RESTORATION; ULTRASONIC TRANSMISSION; ULTRASONICS;

ACOUSTIC WAVES;

ALBUMIN; ANTISENSE PHOSPHOLAMBAN; BETA GALACTOSIDASE; FLUOROCARBON; GLUCOSE; PARVOVIRUS VECTOR; PHOSPHOLAMBAN; SARCOPLASMIC RETICULUM CALCIUM TRANSPORTING ADENOSINE TRIPHOSPHATASE; SERINE; SODIUM CHLORIDE; UNCLASSIFIED DRUG;

ACUTE HEART INFARCTION; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; ECHOGRAPHY; ENZYME ACTIVITY; GENETIC TRANSFECTION; HEART INFARCTION SIZE; HEART LEFT VENTRICLE CONTRACTION; HEART LEFT VENTRICLE EJECTION FRACTION; LEFT ANTERIOR DESCENDING CORONARY ARTERY; MALE; MICROBUBBLE; MOUSE; NONHUMAN; PLASMID; PRIORITY JOURNAL; PROTEIN EXPRESSION; REPORTER GENE; VIRAL GENE DELIVERY SYSTEM; WESTERN BLOTTING;

ANIMALS; BLOTTING, WESTERN; CALCIUM-BINDING PROTEINS; GENE THERAPY; MALE; MICE; MICE, INBRED ICR; MICROBUBBLES; MYOCARDIAL INFARCTION; RNA, ANTISENSE; SARCOPLASMIC RETICULUM CALCIUM-TRANSPORTING ATPASES; SONICATION; SYSTOLE; TRANSFECTION; VENTRICULAR FUNCTION, LEFT;

EID: 70349210131     PISSN: 03015629     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ultrasmedbio.2009.04.018     Document Type: Article

References (37)

1. Bekeredjian R., Chen S., Frenkel P.A., Grayburn P.A., and Shohet R.V. Ultrasound-targeted microbubble destruction can repeatedly direct highly specific plasmid expression to the heart. Circulation 108 (2003) 1022-1026
2. Bekeredjian R., Grayburn P.A., and Shohet R.V. Use of ultrasound contrast agents for gene or drug delivery in cardiovascular medicine. J Am Coll Cardiol 45 (2005) 329-335
3. Champion H.C., Georgakopoulos D., Haldar S., Wang L., Wang Y., and Kass D.A. Robust adenoviral and adeno-associated viral gene transfer to the in vivo murine heart: Application to study of phospholamban physiology. Circulation 108 (2003) 2790-2797
4. Chen S., Shohet R.V., Bekeredjian R., Frenkel P., and Grayburn P.A. Optimization of ultrasound parameters for cardiac gene delivery of adenoviral or plasmid deoxyribonucleic acid by ultrasound-targeted microbubble destruction. J Am Coll Cardiol 42 (2003) 301-308
5. Chu G., and Kranias E.G. Functional interplay between dual site phospholamban phosphorylation: Insights from genetically altered mouse models. Basic Res Cardiol 97 Suppl 1 (2002) I43-I48
6. del Monte F., Harding S.E., Dec G.W., Gwathmey J.K., and Hajjar R.J. Targeting phospholamban by gene transfer in human heart failure. Circulation 105 (2002) 904-907
7. Ding Z., Fach C., Sasse A., Gödecke A., and Schrader J. A minimally invasive approach for efficient gene delivery to rodent hearts. Gene Ther 11 (2004) 260-265
8. Duffield J.S., and Bonventre J.V. Kidney tubular epithelium is restored without replacement with bone marrow-derived cells during repair after ischemic injury. Kidney Int 68 (2005) 1956-1961
9. Eizema K., Fechner H., Bezstarosti K., Schneider-Rasp S., van der Laarse A., Wang H., Schultheiss H.P., Poller W.C., and Lamers J.M. Adenovirus-based phospholamban antisense expression as a novel approach to improve cardiac contractile dysfunction: Comparison of a constitutive viral versus an endothelin-1-responsive cardiac promoter. Circulation 101 (2000) 2193-2199
10. Iwanaga Y., Hoshijima M., Gu Y., Iwatate M., Dieterle T., Ikeda Y., Date M.O., Chrast J., Matsuzaki M., Peterson K.L., Chien K.R., and Ross Jr. J. Chronic phospholamban inhibition prevents progressive cardiac dysfunction and pathological remodeling after infarction in rats. J Clin Invest 113 (2004) 727-736
11. Kadambi V.J., Ponniah S., Harrer J.M., Hoit B.D., Dorn II G.W., Walsh R.A., and Kranias E.G. ardiac-specific overexpression of phospholamban alters calcium kinetics and resultant cardiomyocytes mechanics in transgenic mice. J Clin Invest 97 (1996) 53-59
12. Kondo I., Ohmori K., Oshita A., Takeuchi H., Fuke S., Shinomiya K., Noma T., Namba T., and Kohno M. Treatment of acute myocardial infarction by hepatocyte growth factor gene transfer: The first demonstration of myocardial transfer of a "functional" gene using ultrasonic microbubble destruction. J Am Coll Cardiol 44 (2004) 644-653
13. 2+-dependent pNPPase. Age-dependent changes. Basic Res Cardiol 90 (1995) 323-331
14. Lawrie A., Brisken A.F., Francis S.E., Tayler D.I., Chamberlain J., Crossman D.C., Cumberland D.C., and Newman C.M. Ultrasound enhances reporter gene expression after transfection of vascular cells in vitro. Circulation 20 (1999) 2617-2620
15. Li J., Hu S.J., Sun J., Zhu Z.H., Zheng X., Wang G.Z., Yao Y.M., Chen N.Y., and Zhao X.Y. Construction of phospholamban antisense RNA recombinant adenoassociated virus vector and its effects in rat cardiomyocytes. Acta Pham Sinica 26 (2005) 51-55
16. Li T.S., Hayashi M., Ito H., Furutani A., Murata T., Matsuzaki M., and Hamano K. Regeneration of infarcted myocardium by intramyocardial implantation of ex vivo transforming growth factor-beta-preprogrammed bone marrow stem cells. Circulation 111 (2005) 2438-2445
17. Luo W., Grupp I.L., Harrer J., Ponniah S., Grupp G., Duffy J.J., Doetschman T., and Kranias E.G. Targeted ablation of the phospholamban gene is associated with markedly enhanced myocardial contractility and loss of β-agonist stimulation. Circ Res 75 (1994) 401-409
18. McTiernan C.F., Frye C.S., Lemster B.H., Kinder E.A., Ogletree-Hughes M.L., Moravec C.S., and Feldman A.M. The human phospholamban gene: Structure and expression. J Mol Cell Cardiol 31 (1999) 679-692
19. Matsumoto R., Omura T., Yoshiyama M., Hayashi T., Inamoto S., Koh K.R., Ohta K., Izumi Y., Nakamura Y., Akioka K., Kitaura Y., Takeuchi K., and Yoshikawa J. Vascular endothelial growth factor-expressing mesenchymal stem cell transplantation for the treatment of acute myocardial infarction. Arterioscler Thromb Vasc Biol 25 (2005) 1168-1173
20. Miller D.L., and Quddus J. Diagnostic ultrasound activation of contrast agent gas bodies nduces capillary rupture in mice. Proc Natl Acad Sci USA 97 (2000) 10179-10184
21. Miller D.L., Pislaru S.V., and Greenleaf J.E. Sonoporation: Mechanical DNA delivery by ultrasonic cavitation. Somat Cell Mol Genet 27 (2002) 115-134
22. Pachori A.S., Melo L.G., Zhang L., Loda M., Pratt R.E., and Dzau V.J. Potential for germ line transmission after intramyocardial gene delivery by adeno-associated virus. Biochem Biophys Res Commun 313 (2004) 528-533
23. Periasamy M., Bhupathy P., and Babu G.J. Regulation of sarcoplasmic reticulum Ca2+ATPase pump expression and its relevance to cardiac muscle physiology and pathology. Cardiovasc Res 15 77 (2008) 265-273
24. Roufosse C., Bou-Gharios G., Prodromidi E., Alexakis C., Jeffery R., Khan S., Otto W.R., Alter J., Poulsom R., and Cook H.T. Bone marrow-derived cells do not contribute significantly to collagen I synthesis in a murine model of renal fibrosis. J Am Soc Nephrol 17 (2006) 775-782
25. Sato M., O'Grara P., Harding S.E., and Fuller S.J. Enhancement of adenoviral gene transfer to adult rat cardiomyocytes in vivo by immobilization and ultrasound treatment of the heart. Gene Ther 12 (2005) 936-941
26. 2 activity. Cardiovasc Res 53 (2002) 382-391
27. Schiller N.B., Shah P.M., Crawford M., DeMaria A., Devereux R., Feigenbaum H., Gutgesell H., Reichek N., Sahn D., and Schnittger I. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. J Am Soc Echocardiogr 2 (1989) 358-367
28. Schwinger R.H., Münch G., Bölck B., Karczewski P., Krause E.G., and Erdmann E. Reduced Ca2+-sensitivity of SERCA 2a in failing human myocardium due to reduced serine-16 phospholamban phosphorylation. J Mol Cell Cardiol 31 (1999) 479-491
29. Sheehan F.H., Bolson E.L., Dodge H.T., Mathey D.G., Schofer J., and Woo H.W. Advantages and applications of the centerline method for characterizing regional ventricular function. Circulation 74 (1986) 293-305
30. Shohet R.V., Chen S., Zhou Y.T., Wang Z., Meidell R.S., Unger R.H., and Grayburn P.A. Echocardiographic destruction of albumin microbubbles directs gene delivery to the myocardium. Circulation 101 (2000) 2554-2556
31. Sjaastad I., Wasserstrom J.A., and Sejersted O.M. Heart failure-A challenge to our current concepts of excitation-contraction coupling. J Physiol 546 (2003) 33-47
32. Sun Y.L., Hu S.J., Wang L.H., Hu Y., and Zhou J.Y. Comparison of low and high doses of carvedilol on restoration of cardiac function and calcium-handling proteins in rat failing heart. Clin Exp Pharmacol Physiol 32 (2005) 553-560
33. Taniyama Y., Tachibana K., Hiraoka K., Namba T., Yamasaki K., Hashiva N., Aoki M., Oqihara T., Yasufumi K., and Morishita R. Local delivery of plasmid DNA into rat carotid artery using ultrasound. Circulation 105 (2002) 1233-1239
34. Traaseth N.J., Ha K.N., Verardi R., Shi L., Buffy J.J., Masterson L.R., and Veglia G. Structural and dynamic basis of phospholamban and sarcolipin inhibition of Ca(2+)-ATPase. Biochemistry 47 (2008) 3-13
35. Tsunoda S., Mazda O., Oda Y., Iida Y., Akabame S., Kishida T., Shin-Ya M., Asada H., Gojo S., Imanishi J., Matsubara H., and Yoshikawa T. Sonoporation using microbubble BR14 promotes pDNA/siRNA transduction to murine heart. Biochem Biophys Res Commun 336 (2005) 118-127
36. Zhai J., Schmidt A.G., Hoit B.D., Kimura Y., MacLennan D.H., and Kranias E.G. Cardiac-specific overexpression of a superinhibitory pentameric phospholamban mutant enhances inhibition of cardiac function in vivo. J Biol Chem 275 (2000) 10538-10544
37. Zhao X.Y., Hu S.J., Li J., Mou Y., Bian K., Sun J., and Zhu Z.H. rAAV-asPLB transfer attenuates abnormal sarcoplasmic reticulum Ca(2+)-ATPase activity and cardiac dysfunction in rats with myocardial infarction. Eur J Heart Fail 10 (2008) 47-54